Copyright: ©Author(s) 2026.
World J Stem Cells. Jun 26, 2026; 18(6): 116526
Published online Jun 26, 2026. doi: 10.4252/wjsc.116526
Published online Jun 26, 2026. doi: 10.4252/wjsc.116526
Figure 11 Serum levels of interleukin-6, interleukin-10, tumor necrosis factor-α, and soluble fms-like tyrosine kinase-1.
A: Interleukin-6; B: Interleukin-10; C: Tumor necrosis factor-α; D: Soluble fms-like tyrosine kinase-1. aP < 0.05, compared to the normal pregnancy group; bP < 0.05, compared to the preeclampsia group. IL: Interleukin; TNF: Tumor necrosis factor; sFLT-1: Soluble fms-like tyrosine kinase-1; NP: Normal pregnancy; PE: Preeclampsia; hAECs-exos: Human amniotic epithelial cell exosomes; hucbMSCs-exos: Exosomes from mesenchymal stem cells derived from human umbilical cord blood.
- Citation: Han LY, Zhang WZ, Zhang Y, Zhong W, Sun JL, Shen J. Therapeutic effects of human amniotic epithelial cell-derived and umbilical cord blood mesenchymal stem cell-derived exosomes on preeclamptic rats. World J Stem Cells 2026; 18(6): 116526
- URL: https://www.wjgnet.com/1948-0210/full/v18/i6/116526.htm
- DOI: https://dx.doi.org/10.4252/wjsc.116526